The SCR 18: CRO league tables
29 September 2011 | Joanne Payne Scrip Clinical Research
China, India To Propel Private Healthcare Surge In EMs Medtech Exits, Funding Prospects Are Getting Better Oncobiologics raises $31m for biosimilars; RaNA, Ra, SutroVax add VC cash Enter Tata Capital as Sequoia exits Sai Life?
Other Features & Analysis
Costs for cancer drugs, combos face increasing scrutiny Should innovator pharma companies be pursuing biosimilars? Why innovator pharma companies should be pursuing biosimilars INTERVIEW: Aseptika crosses chasm between consumer and medtech